Detailed information for compound 1803166

Basic information

Technical information
  • Name: Unnamed compound
  • MW: 324.423 | Formula: C18H24N6
  • H donors: 2 H acceptors: 3 LogP: 3.16 Rotable bonds: 6
    Rule of 5 violations (Lipinski): 1
  • SMILES: CC(Nc1nc(CNC(C)C)nc2c1cnn2c1ccccc1)C
  • InChi: 1S/C18H24N6/c1-12(2)19-11-16-22-17(21-13(3)4)15-10-20-24(18(15)23-16)14-8-6-5-7-9-14/h5-10,12-13,19H,11H2,1-4H3,(H,21,22,23)
  • InChiKey: GXSAOLYYVLNYCE-UHFFFAOYSA-N  

Network

Hover on a compound node to display the structore

Synonyms

No synonyms found for this compound

Targets

Known targets for this compound

No curated genes were found associated with this compound

Predicted pathogen targets for this compound

By orthology
No druggable targets predicted by orthology data
By sequence similarity to non orthologous known druggable targets
No druggable targets predicted by sequence similarity

Obtained from network model

Ranking Plot


Putative Targets List


Species Potential target Raw Global Species
Trichomonas vaginalis dihydrodiol dehydrogenase, putative 0.0031 1 1
Trypanosoma brucei DNA polymerase kappa, putative 0.0021 0.4091 0.4091
Onchocerca volvulus 0.0031 1 0.5
Echinococcus granulosus aldo keto reductase family 1 member B4 0.0031 1 1
Echinococcus granulosus aldo keto reductase 0.0031 1 1
Trypanosoma brucei DNA polymerase kappa, putative 0.0021 0.4091 0.4091
Trypanosoma brucei unspecified product 0.0021 0.4091 0.4091
Giardia lamblia Aldose reductase 0.0031 1 1
Trichomonas vaginalis aldo/keto reductase, putative 0.0031 1 1
Leishmania major prostaglandin f2-alpha synthase/D-arabinose dehydrogenase 0.0031 1 1
Trichomonas vaginalis aldo-keto reductase, putative 0.0031 1 1
Trichomonas vaginalis aldo-keto reductase, putative 0.0031 1 1
Trypanosoma brucei DNA polymerase kappa, putative 0.0021 0.4091 0.4091
Trichomonas vaginalis aldo-keto reductase, putative 0.0031 1 1
Echinococcus granulosus aldo keto reductase family 1 member B4 0.0031 1 1
Schistosoma mansoni aldo-keto reductase 0.0031 1 1
Trypanosoma brucei DNA polymerase IV, putative 0.0021 0.4091 0.4091
Brugia malayi oxidoreductase, aldo/keto reductase family protein 0.0031 1 1
Schistosoma mansoni aldo-keto reductase 0.0031 1 1
Loa Loa (eye worm) oxidoreductase 0.0031 1 1
Brugia malayi oxidoreductase, aldo/keto reductase family protein 0.0031 1 1
Echinococcus multilocularis aldo keto reductase family 1, member B4 0.0031 1 1
Echinococcus granulosus aldo keto reductase family 1 member B4 0.0031 1 1
Loa Loa (eye worm) oxidoreductase 0.0031 1 1
Trichomonas vaginalis aldo-keto reductase, putative 0.0031 1 1
Trichomonas vaginalis aldo-keto reductase, putative 0.0031 1 1
Mycobacterium tuberculosis Probable oxidoreductase 0.0031 1 1
Leishmania major aldo-keto reductase-like protein 0.0031 1 1
Echinococcus multilocularis aldo keto reductase 0.0031 1 1
Trypanosoma brucei aldo-keto reductase, putative 0.0031 1 1
Echinococcus granulosus aldo keto reductase 0.0031 1 1
Trypanosoma brucei DNA polymerase kappa, putative 0.0021 0.4091 0.4091
Entamoeba histolytica aldose reductase, putative 0.0031 1 1
Loa Loa (eye worm) oxidoreductase 0.0031 1 1
Trichomonas vaginalis aldo/keto reductase, putative 0.0031 1 1
Echinococcus granulosus aldo keto reductase family 1 member B4 0.0031 1 1
Entamoeba histolytica aldose reductase, putative 0.0031 1 1
Echinococcus granulosus aldehyde reductase 0.0022 0.4471 0.0643
Trichomonas vaginalis aldo-keto reductase, putative 0.0031 1 1
Echinococcus multilocularis aldo keto reductase family 1, member B4 0.0031 1 1
Trichomonas vaginalis aldo-keto reductase, putative 0.0031 1 1
Trichomonas vaginalis aldo-keto reductase, putative 0.0031 1 1
Leishmania major prostaglandin f synthase, putative 0.0031 1 1
Mycobacterium leprae PROBABLE OXIDOREDUCTASE 0.0031 1 1
Echinococcus multilocularis aldehyde reductase 0.0022 0.4471 0.0643
Echinococcus granulosus aldo keto reductase family 1 member B4 0.0031 1 1
Echinococcus multilocularis aldo keto reductase family 1, member B4 0.0031 1 1
Onchocerca volvulus 0.0031 1 0.5
Onchocerca volvulus 0.0031 1 0.5
Trichomonas vaginalis aldo/keto reductase, putative 0.0031 1 1
Echinococcus multilocularis aldo keto reductase family 1, member B4 0.0031 1 1
Onchocerca volvulus 0.0031 1 0.5
Trichomonas vaginalis dihydrodiol dehydrogenase, putative 0.0031 1 1
Trichomonas vaginalis dihydrodiol dehydrogenase, putative 0.0031 1 1
Echinococcus multilocularis aldo keto reductase 0.0031 1 1
Echinococcus granulosus aldo keto reductase family 1 member B4 0.0031 1 1
Echinococcus multilocularis aldo keto reductase family 1, member B4 0.0031 1 1
Loa Loa (eye worm) oxidoreductase 0.0031 1 1
Trypanosoma cruzi aldo/keto reductase, putative 0.0031 1 1
Echinococcus granulosus aldo keto reductase family 1 member B4 0.0031 1 1
Leishmania major aldehyde reductase, putative,oxidoreductase, putative 0.0031 1 1
Loa Loa (eye worm) oxidoreductase 0.0031 1 1
Trypanosoma brucei DNA polymerase kappa, putative 0.0021 0.4091 0.4091
Onchocerca volvulus 0.0031 1 0.5
Schistosoma mansoni pol-related 0.0031 1 1
Echinococcus multilocularis aldo keto reductase 0.0031 1 1
Trichomonas vaginalis aldo-keto reductase, putative 0.0031 1 1
Loa Loa (eye worm) hypothetical protein 0.0031 1 1
Trypanosoma brucei DNA polymerase kappa, putative 0.0021 0.4091 0.4091
Echinococcus multilocularis aldo keto reductase family 1, member B4 0.0031 1 1
Trypanosoma brucei DNA polymerase eta, putative 0.0021 0.4091 0.4091
Giardia lamblia Aldose reductase 0.0031 1 1
Trypanosoma brucei DNA polymerase kappa, putative 0.0021 0.4091 0.4091
Trypanosoma brucei DNA polymerase kappa, putative 0.0021 0.4091 0.4091
Echinococcus multilocularis aldo keto reductase 0.0031 1 1
Entamoeba histolytica aldose reductase, putative 0.0031 1 1
Echinococcus granulosus aldo keto reductase 0.0031 1 1
Trypanosoma brucei DNA polymerase kappa, putative 0.0021 0.4091 0.4091
Echinococcus multilocularis aldo keto reductase family 1, member B4 0.0031 1 1
Echinococcus granulosus aldo keto reductase family 1 member B4 0.0031 1 1
Echinococcus multilocularis aldo keto reductase family 1, member B4 0.0031 1 1
Trichomonas vaginalis aldo-keto reductase, putative 0.0031 1 1
Trypanosoma brucei DNA polymerase kappa, putative 0.0021 0.4091 0.4091
Trichomonas vaginalis aldo-keto reductase, putative 0.0031 1 1
Brugia malayi oxidoreductase, aldo/keto reductase family protein 0.0031 1 1
Mycobacterium ulcerans oxidoreductase 0.0031 1 1
Trypanosoma cruzi aldo-keto reductase 0.0031 1 1
Trypanosoma brucei prostaglandin f synthase 0.0031 1 1
Echinococcus multilocularis aldo keto reductase family 1, member B4 0.0031 1 1
Echinococcus granulosus aldo keto reductase family 1 member B4 0.0031 1 1
Trypanosoma brucei DNA polymerase IV, putative 0.0021 0.4091 0.4091
Echinococcus multilocularis aldo keto reductase family 1, member B4 0.0031 1 1
Toxoplasma gondii aldose reductase, putative 0.0031 1 0.5
Trypanosoma brucei DNA polymerase IV, putative 0.0021 0.4091 0.4091
Echinococcus multilocularis aldo keto reductase family 1, member B4 0.0031 1 1
Onchocerca volvulus 0.0031 1 0.5
Trichomonas vaginalis aldo-keto reductase, putative 0.0031 1 1
Echinococcus granulosus hypothetical protein 0.0031 1 1

Activities

Activity type Activity value Assay description Source Reference
GI50 (functional) > 1 10'-4M Cytotoxicity against Homo sapiens (human) G361 cells by SRB assay ChEMBL. No reference
IZ (functional) = 1.3 mm Antibacterial activity against Escherichia coli NCIM 2803 at 20 ug/ml after 24 hr by agar diffusion method ChEMBL. No reference

Phenotypes

Whole-cell/tissue/organism interactions

We have no records of whole-cell/tissue assays done with this compound What does this mean?

Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.

Annotated phenotypes:

We have no manually annotated phenotypes for this drug. What does this mean? / Care to help?
In TDR Targets, information about phenotypes that are caused by drugs, or by genetic manipulation of cells (e.g. gene knockouts or knockdowns) is manually curated from the literature. These descriptions help to describe the potential of the target for drug development. If no information is available for this gene or if the information is incomplete, this may mean that i) the papers containing this information either appeared after the curation effort for this organism was carried out or they were inadvertently missed by curators; or that ii) the curation effort for this organism has not yet started.
 
In any case, if you have information about papers containing relevant validation data for this target, please log in using your TDR Targets username and password and send them to us using the corresponding form in this page (only visible to registered users) or contact us.

External resources for this compound

Bibliographic References

No literature references available for this target.

If you have references for this compound, please enter them in a user comment (below) or Contact us.